[Comment on “Atrial fibrillation ablation patients have long‐term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score”].
Atrial fibrillation (AF) is a leading cause of total and fatal ischemic stroke. Stroke risk after AF ablation appears to be favorably affected; however, it is largely unknown whether the benefit extends to all stroke CHADS2 risk profiles of AF patients. To determine if ablation of atrial fibrillation reduces stroke rates in all risk groups. A total of 4212 consecutive patients who underwent AF ablation were compared (1:4) with 16,848 age-/sex-matched controls with AF (no ablation) and to 16,848 age-/sex-matched controls without AF. Patients were enrolled from the large ongoing prospective Intermountain Atrial Fibrillation Study and were followed for at least 3 years. Of the 37,908 patients, the mean age was 65.0 ・} 13 years and 4.4% (no AF), 6.3% (AF, no ablation), and 4.5% (AF ablation) patients had a prior stroke (p < .0001). The profile of CHADS2 scores between comparative groups was (AF ablation) patients had a prior stroke (p < .0001). The profile of CHADS2 scores between comparative groups was similar: 0---1 (69.3%, no AF; 62.3%, AF, no ablation; 63.6%, AF ablation), 2---3 (26.5%, no AF; 29.7%, AF, no ablation; 28.7%, AF ablation), and ≥ 4 (4.3%, no AF; 8.0%, AF, no ablation; 7.7%, AF ablation). A total of 1296 (3.4%) patients had a stroke over the follow-up period. Across all CHADS2 profiles and ages, AF patients with ablation had a lower long-term risk of stroke compared to patients without ablation. Furthermore, AF ablation patients had similar long-term risks of stroke across all CHADS2 profiles and ages compared to patients with no history of AF. In our study populations, AF ablation patients have a significantly lower risk of stroke compared to AF patients who do not undergo ablation independent of baseline stroke risk score.